TherapeuticsMD, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.5M | $5.1M | $4.3M | $49.3M | $64.9M | $80.5M | $160.8M | $161.6M |
| Accounts Receivable | — | — | — | — | $36.2M | $32.4M | $24.4M | $11.1M |
| Inventory | — | — | — | — | $7.6M | $8.0M | $11.9M | $3.3M |
| Total Current Assets | $14.4M | $12.3M | $11.8M | $55.4M | $119.5M | $128.4M | $208.4M | $186.8M |
| Property, Plant & Equipment | — | — | — | $78.0K | $823.0K | $1.9M | $2.5M | $472.7K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $3.8M | $4.3M | $6.1M | $6.9M | $7.1M | $41.4M | $5.3M | $4.1M |
| Total Assets | $37.7M | $38.8M | $43.3M | $90.5M | $169.5M | $181.6M | $266.0M | $212.0M |
| Liabilities | ||||||||
| Accounts Payable | $377.0K | $258.0K | $27.0K | $2.2M | $3.4M | $21.1M | $19.2M | $22.7M |
| Total Current Liabilities | $4.8M | $5.2M | $6.9M | $46.8M | $252.9M | $59.2M | $53.0M | $41.1M |
| Long-Term Debt | — | — | — | — | $0 | $237.7M | $194.6M | $73.4M |
| Total Liabilities | $10.8M | $11.5M | $14.0M | $55.3M | $263.1M | $305.6M | $256.8M | $114.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-952.4M | $-951.8M | $-949.6M | $-939.4M | $-1.05B | $-878.9M | $-695.4M | $-519.3M |
| Total Stockholders' Equity | $26.9M | $27.4M | $29.3M | $35.1M | $-93.6M | $-124.0M | $9.2M | $97.5M |